Comparison of the INNO-LiPA and PapType Assays for Detection of Human Papillomavirus in Archival Vulva Dysplasia and/or Neoplasia Tissue Biopsy Specimens
Sarah E Tan, Suzanne M Garland, Alice R Rumbold, Sepehr N Tabrizi
Journal of Clinical Microbiology | AMER SOC MICROBIOLOGY | Published : 2011
S.E.T. was supported by The Royal Women's Hospital Post Graduate Degree Scholarship from The Royal Women's Hospital and the Women's Centre for Infectious Diseases, The Royal Women's Hospital, Melbourne, Australia. A. R. R. is supported by the Jean B. Reid Fellowship from the University of Adelaide Medical Endowment Funds.S.M.G. and S.N.T. were previously members of the clinical development advisory board at Genera Biosystems; however, this advisory board has ceased to exist. S. M. G. has received advisory board fees and grant support from CSL Biotherapies and GlaxoSmithKline (GSK), lecture fees from Merck, GSK, and Sanofi Pasteur, and funding (through her employing institution) to conduct HPV vaccine studies for Merck, Sharp and Dohme (MSD) and GSK and is a member of the Merck Global Advisory Board and the Merck Scientific Advisory Committee for HPV. This relates to work outside this study. S. E. T. is the recipient of a GSK Australian Postgraduate Support Grant for work outside this study. CSL has provided funding to the authorship group to support a workshop on genetic susceptibility to vulvar cancer.